<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Otitis media with effusion (serous otitis media) in children: Management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Otitis media with effusion (serous otitis media) in children: Management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Otitis media with effusion (serous otitis media) in children: Management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Tal Marom, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn C Isaacson, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 26, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H976032098">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Otitis media with effusion (OME  (
         <a class="graphic graphic_picture graphicRef103802" href="/z/d/graphic/103802.html" rel="external">
          picture 1
         </a>
         )), also called serous otitis media or "glue ear," is defined as the presence of middle ear fluid without signs of acute infection [
         <a href="#rid1">
          1
         </a>
         ]. OME often occurs after acute otitis media (AOM), but it also may occur as a result of Eustachian tube dysfunction in young children in the absence of a preceding AOM.
        </p>
        <p>
         In general, OME is a spontaneously resolving condition, and watchful observation is the preferred strategy, except for children with hearing impairment, developmental delay, or specific conditions (such as cleft palate) in whom OME is often persistent and needs to be addressed. The management of OME will be reviewed here. The clinical features and diagnosis of OME and the clinical features, diagnosis, treatment, and prevention of AOM are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6009.html" rel="external">
          "Acute otitis media in children: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3441164557">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Otitis media with effusion (OME) or serous otitis media – Presence of middle ear fluid without acute signs of infection  (
         <a class="graphic graphic_picture graphicRef103802" href="/z/d/graphic/103802.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic OME – OME that persists for ≥3 months on otoscopic examination (with or without pneumatic otoscopy), tympanometry, or both. (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         "Glue ear" – Long-standing OME in which the middle ear fluid has become thick, yellowish, and glue-like (as seen during myringotomy) [
         <a href="#rid2">
          2
         </a>
         ]; sometimes used synonymously with OME but should be reserved for the subset with thick middle ear fluid.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tympanometry – An examination used to evaluate the condition of the middle ear and the mobility of the tympanic membrane and the ossicles by measuring the transmission of sound energy through the tympanic membrane over a range of air pressures in the external canal  (
         <a class="graphic graphic_figure graphicRef67750" href="/z/d/graphic/67750.html" rel="external">
          figure 1
         </a>
         ). Type "A" is considered normal; Type "B" indicates OME, tympanic membrane perforation, or cerumen impaction; and Type "C" indicates Eustachian tube dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         "Tympanostomy tube," "ventilating tube," "grommet," or "pressure equalizer" – A small tube inserted into the tympanic membrane to keep the middle ear aerated for a prolonged period and to prevent the accumulation of fluid in the middle ear. Long-term tubes such as silicon T-tubes are not self-extruding and are usually kept for approximately two years in patients with recurrent OME, after at least one previous tympanostomy tube insertion. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H377254594">
         <span class="h1">
          NATURAL HISTORY
         </span>
         <span class="headingEndMark">
          —
         </span>
         OME usually resolves spontaneously [
         <a href="#rid3">
          3-6
         </a>
         ]. Approximately 30 to 40 percent of children have recurrent episodes [
         <a href="#rid7">
          7,8
         </a>
         ]. Although OME associated with acute otitis media (AOM) usually persists beyond the resolution of the acute symptoms of AOM, it also generally resolves spontaneously within several weeks, often less than four to six weeks  (
         <a class="graphic graphic_figure graphicRef81406" href="/z/d/graphic/81406.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid9">
          9-11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Clinical course without antibiotics'
         </a>
         .)
        </p>
        <p>
         Some children develop chronic OME, defined as OME that persists for three months or longer. Patients with chronic OME may have problems related to the associated, often fluctuating, conductive hearing loss. Rarely, the chronic Eustachian tube dysfunction that results in OME persists for years, and the patient may develop long-term sequelae due to retraction (also known as atelectasis) of the tympanic membrane including retraction pockets, ossicular erosion, chronic tympanic membrane perforation, or cholesteatoma. (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis", section on 'Complications and sequelae'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1751537544">
         <span class="h1">
          OME-ASSOCIATED HEARING LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         OME causes an average hearing loss of 20 to 28 dB [
         <a href="#rid12">
          12-14
         </a>
         ]. Although OME-associated hearing loss is seldom &gt;50 dB, approximately 20 percent of children with OME have hearing thresholds &gt;35 dB [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H170941090">
         <span class="h1">
          APPROACH TO MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H1702825961">
         <span class="h2">
          Choice of intervention
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goals of management are to clear the middle ear fluid and restore normal middle ear pressure and hearing. The primary management options are "watchful waiting" and myringotomy with tympanostomy tube placement (with or without adenoidectomy). Myringotomy alone – without the insertion of a tympanostomy tube – is ineffective in the management of OME. Although it appears promising, additional information about endoscopic balloon dilation of the Eustachian tube is necessary before its effectiveness and adverse event profile are fully appreciated. (See
         <a class="local">
          'Primary interventions'
         </a>
         below and
         <a class="local">
          'Myringotomy'
         </a>
         below and
         <a class="local">
          'Balloon dilation of the Eustachian tube'
         </a>
         below.)
        </p>
        <p>
         Which option is undertaken and when depends upon the presence or absence of comorbid conditions that increase the impact of conductive hearing loss on speech, language, or learning problems; the severity of OME-associated hearing loss; the duration of the effusion; and whether it is unilateral or bilateral  (
         <a class="graphic graphic_algorithm graphicRef117272" href="/z/d/graphic/117272.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ]. Seasonality also may play a role. Onset in the summer or fall is associated with a lack of spontaneous resolution [
         <a href="#rid1">
          1,15,16
         </a>
         ]. When all factors are considered, the balance of risks and benefits will favor watchful waiting for most children and the placement of tympanostomy tubes in some.
        </p>
        <p>
         Hearing aids (worn and implantable) are reserved for the rare cases of children with chronic OME who cannot undergo or benefit from tympanostomy tube placement (ie, aural atresia, ossicular dysfunction). (See
         <a class="local">
          'Hearing aids'
         </a>
         below.)
        </p>
        <p>
         Unproven and/or ineffective interventions that are not recommended and discussed below include antibiotics, antihistamines, oral and intranasal glucocorticoids, nasal balloon autoinflation, and complementary and alternative therapies. (See
         <a class="local">
          'Unproven or ineffective interventions'
         </a>
         below.)
        </p>
        <p>
         The recommendations provided in this topic review are generally consistent with those of professional society guidelines [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H377255892">
         <span class="h2">
          Children at risk for speech, language, or learning issues
         </span>
         <span class="headingEndMark">
          —
         </span>
         "At-risk" children are those who have or are at risk for speech, language, or learning problems. This includes children with hearing loss independent of OME and children with neurodevelopmental or genetic disorders (eg, Down syndrome, 22q11.2 deletion syndrome, autism spectrum disorder, intellectual disability, learning disorder, attention deficit hyperactivity disorder), craniofacial abnormalities (eg, cleft palate), and uncorrectable visual impairment (who depend on hearing more than children with normal vision) [
         <a href="#rid1">
          1,2,17
         </a>
         ].
        </p>
        <p>
         We perform hearing evaluations in children who are at risk for speech, language, or learning disorders if OME persists for &gt;4 weeks. The conductive hearing loss associated with OME has a more significant impact on children with disabilities. The type of testing depends upon the age of the child and their ability to cooperate with testing. If hearing impairment is significant, surgery is recommended. In addition, children with speech delays should be referred for speech and language evaluation. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/619.html" rel="external">
          "Evaluation and treatment of speech and language disorders in children"
         </a>
         .)
        </p>
        <p>
         We agree with professional society recommendations for early surgical referral (ie, within three months) for children with OME who are at risk for speech, language, or learning problems  (
         <a class="graphic graphic_algorithm graphicRef117272" href="/z/d/graphic/117272.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid1">
          1,17
         </a>
         ]. These at-risk children typically have been excluded from most studies evaluating the short- and long-term consequences of OME [
         <a href="#rid18">
          18
         </a>
         ]. However, it is reasonable to assume that the conductive hearing loss associated with chronic middle ear effusion presence may increase the risk of speech, language, or learning problems in children with baseline risk factors [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="local">
          'Tympanostomy tubes'
         </a>
         below.)
        </p>
        <p>
         At-risk children also may be candidates for hearing aids or amplification devices for hearing loss independent of OME [
         <a href="#rid1">
          1
         </a>
         ]. They also may require speech and language therapy independent of OME. (See
         <a class="medical medical_review" href="/z/d/html/619.html" rel="external">
          "Evaluation and treatment of speech and language disorders in children", section on 'Treatment'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6298.html" rel="external">
          "Hearing loss in children: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H377255869">
         <span class="h2">
          Children not at risk for speech, language, or learning issues
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with OME who are not at risk for speech, language, or learning problems typically undergo hearing evaluation if OME has persisted for three months or longer (ie, chronic OME) [
         <a href="#rid1">
          1,17
         </a>
         ]. Waiting for three months to evaluate the hearing of these children allows sufficient time for spontaneous resolution in many cases [
         <a href="#rid2">
          2
         </a>
         ]. Speech and language evaluation also may be warranted, particularly if hearing loss with a hearing threshold of ≥16 dB is detected. (See
         <a class="medical medical_review" href="/z/d/html/619.html" rel="external">
          "Evaluation and treatment of speech and language disorders in children"
         </a>
         .)
        </p>
        <p>
         The management strategy for children who are not at risk depends upon the condition of the tympanic membrane and middle ear, the results of the hearing evaluation (audiometry and tympanometry), the duration of the effusion, whether the fluid is unilateral or bilateral, and the preferences of the parents or caregivers  (
         <a class="graphic graphic_algorithm graphicRef117272" href="/z/d/graphic/117272.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H541197036">
         <span class="h3">
          Structural damage to the tympanic membrane or middle ear
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prompt surgical referral is warranted for children with structural changes of the tympanic membrane or middle ear (eg, retraction [also known as atelectasis], retraction pocket  (
         <a class="graphic graphic_picture graphicRef103800 graphicRef103801" href="/z/d/graphic/103800.html" rel="external">
          picture 2A-B
         </a>
         )), tympanic membrane perforation, otorrhea, or cholesteatoma  (
         <a class="graphic graphic_picture graphicRef76079 graphicRef103803" href="/z/d/graphic/76079.html" rel="external">
          picture 3A-B
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. Such children may require surgery independent of OME. (See
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children", section on 'Surgical treatment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H976032870">
         <span class="h3">
          Hearing threshold ≥41 dB
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend that children with persistent OME-associated conductive hearing loss with a hearing threshold of ≥41 dB be referred for surgical evaluation. (See
         <a class="local">
          'Tympanostomy tubes'
         </a>
         below.)
        </p>
        <p>
         There are few studies evaluating the long-term outcome of children with OME-associated hearing loss at this level. However, as permanent hearing loss of this magnitude may affect speech, language, and academic performance, we recommend referral to otolaryngology [
         <a href="#rid20">
          20-22
         </a>
         ].
        </p>
        <p>
         A systematic review of randomized trials in children with OME found that the benefit of tympanostomy tubes on hearing appears modest and short lived and diminishes after six to nine months (similar to the duration of natural resolution) [
         <a href="#rid18">
          18
         </a>
         ]. Although no effect was found on speech, language, or cognitive outcomes, data for these outcomes were sparse. Studies in children with established speech, language, developmental, or learning problems are lacking.
        </p>
        <p class="headingAnchor" id="H377255937">
         <span class="h3">
          Hearing threshold 16 to 40 dB
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of OME-associated conductive hearing loss with a hearing threshold of 16 to 40 dB (ie, slight/mild hearing loss) in children without speech, language, or learning problems is determined on a case-by-case basis, after a discussion of the risks and benefits of watchful waiting versus tympanostomy tube placement with the parents/caregivers and/or the patient [
         <a href="#rid1">
          1,2,17
         </a>
         ]. In most cases, there is no need for surgery and a "wait-and-see" approach is sufficient. Follow-up is usually recommended with repeat hearing evaluation within three to six months. (See
         <a class="local">
          'Tympanostomy tubes'
         </a>
         below and
         <a class="local">
          'Watchful waiting'
         </a>
         below.)
        </p>
        <p>
         The balance of risks and benefits is determined largely by the auditory deprivation associated with mild hearing loss for six to nine months (the period during which the primary benefit of tympanostomy tubes is expected); however, systematic reviews of randomized trials and other controlled studies have found no compelling evidence that early insertion of tympanostomy tubes impacts speech and language development in children with mild conductive hearing loss [
         <a href="#rid9">
          9,18,23,24
         </a>
         ]. Tympanostomy tubes may be warranted for children with unilateral or bilateral OME for three months or longer (chronic OME)
         <strong>
          and
         </strong>
         symptoms that are likely attributable to OME (including poor school performance, behavioral problems, or reduced quality of life) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Definitive long-term evidence of improvement for most outcomes following tympanostomy tube placement is lacking. Tympanostomy tube insertion is associated with short- and intermediate-term resolution of hearing loss, and caregivers have reported postoperative improvements in language skills. However, long-term benefits have not been established because resolution of middle ear effusion usually occurs spontaneously within six to nine months. Another potential benefit may be a small reduction in recurrent acute otitis media (AOM) episodes [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="local">
          'Potential benefits'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence", section on 'Potential benefits'
         </a>
         .)
        </p>
        <p>
         Factors that should be considered in the decision include [
         <a href="#rid1">
          1,2,17,26
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Delayed or abnormal language in the young child or poor school performance associated with behavioral abnormalities in the older child.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bilateral OME of ≥3 months' duration; in observational studies, bilateral OME has been associated with more severe hearing loss and decreased rates of spontaneous resolution (approximately 25 percent at 6 months and 30 percent at 12 months) [
         <a href="#rid1">
          1,2,27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unilateral or bilateral OME for three months or longer (chronic OME)
         <strong>
          and
         </strong>
         symptoms that are likely attributable to OME, which include, but are not limited to, balance (vestibular) problems, poor school performance, behavioral problems, ear discomfort, or reduced quality of life (eg disturbed sleep, behavior change) as perceived by the parents or caregivers [
         <a href="#rid28">
          28-30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prolonged duration (eg, unilateral OME for ≥6 months or cumulative duration of OME for ≥6 of the past 12 months); prolonged duration is associated with a diminished likelihood of spontaneous resolution [
         <a href="#rid5">
          5
         </a>
         ] and increased risk of structural damage to the tympanic membrane [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age &lt;3 years (a critical time for speech and language development) [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recurrent AOM episodes, defined as ≥3 episodes in 6 months or ≥4 episodes in 12 months if middle ear fluid is present at the time of assessment for tympanostomy tube placement in at least one ear [
         <a href="#rid17">
          17
         </a>
         ]; recurrent AOM episodes increase the cumulative duration of middle ear effusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Season; onset in the summer or fall is associated with a lack of spontaneous resolution [
         <a href="#rid1">
          1,15,16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Home environment that is not conducive to language development (eg, does not provide academic and language stimulation) [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H976033040">
         <span class="h3">
          Normal hearing
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend that children without speech, language, or developmental problems and normal hearing (ie, hearing loss with a threshold of ≤15 dB) be managed with watchful waiting for an additional three months (the first three months of watchful waiting typically occur before the hearing evaluation) [
         <a href="#rid1">
          1,2
         </a>
         ]. OME is likely to resolve spontaneously in such children, and there is no demonstrated risk associated with watchful waiting. (See
         <a class="local">
          'Natural history'
         </a>
         above and
         <a class="local">
          'Watchful waiting'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H952291298">
         <span class="h2">
          Recurrence after tympanostomy tube extrusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recurrence of OME is common after tympanostomy tube extrusion. In observational and randomized trials, up to 50 percent of children who have undergone tympanostomy tube placement for persistent OME required a second procedure [
         <a href="#rid33">
          33-36
         </a>
         ].
        </p>
        <p>
         The preferred procedure(s) depends on age [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          &lt;4 years
         </strong>
         – For children &lt;4 years who develop recurrent persistent OME after extrusion of tympanostomy tubes and require repeat surgery, repeat tympanostomy tube placement without adenoidectomy is preferred unless there is a separate and distinct indication for adenoidectomy (eg, nasal obstruction, obstructive sleep apnea). (See
         <a class="medical medical_review" href="/z/d/html/6296.html" rel="external">
          "Tonsillectomy and/or adenoidectomy in children: Indications and contraindications", section on 'Adenoidectomy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ≥4 years
         </strong>
         – For children ≥4 years who develop recurrent persistent OME after extrusion of tympanostomy tubes and require repeat surgery, tympanostomy tube placement, with or without adenoidectomy, has been demonstrated to be of value.
        </p>
        <p>
        </p>
        <p>
         In systematic reviews and meta-analyses of randomized trials, the addition of adenoidectomy was associated with improved rates of resolution and decreased rates of additional surgery in children ≥4 years [
         <a href="#rid37">
          37,38
         </a>
         ]. Information regarding the additive effect on OME when adenoidectomy was also performed in children &lt;4 years was limited, and the potential risks (eg, velopharyngeal insufficiency, more complex anesthesia) outweighed the uncertain benefits [
         <a href="#rid1">
          1,37,38
         </a>
         ]. (See
         <a class="local">
          'Adenoidectomy'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6296.html" rel="external">
          "Tonsillectomy and/or adenoidectomy in children: Indications and contraindications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H377254760">
         <span class="h1">
          PRIMARY INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H377254982">
         <span class="h2">
          Watchful waiting
         </span>
        </p>
        <p class="headingAnchor" id="H1496834378">
         <span class="h3">
          Potential indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         "Watchful waiting" for three months from the onset of the effusion (or the diagnosis of effusion if the date of onset is not known) is recommended for children who have OME; are not at risk for speech, language, or learning problems; and otherwise have normal hearing (ie, hearing threshold ≤15 dB) [
         <a href="#rid1">
          1,2,17
         </a>
         ]. Watchful waiting is also an option for children who have OME; are not at risk for speech, language, or learning problems; and whose OME-associated conductive hearing loss is slight/mild (ie, hearing threshold of 16 to 40 dB). The recommendation for watchful waiting is based on the high likelihood of spontaneous resolution of OME during the first three to six months [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="local">
          'Natural history'
         </a>
         above.)
        </p>
        <p>
         During the period of watchful waiting, slight/mild conductive hearing loss (ie, hearing threshold of 16 to 40 dB) can be addressed by speaking in close proximity to the child, facing the child and speaking clearly, repeating phrases when misunderstood, providing preferential classroom seating, and/or having the teacher use a frequency modulated (FM) system in the classroom [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         Systematic reviews, randomized trials, and other controlled studies of the use of tympanostomy tubes for OME-associated hearing loss support a strategy of watchful waiting rather than immediate placement of tympanostomy tubes [
         <a href="#rid18">
          18,24
         </a>
         ]. Children who received tympanostomy tubes spent 32 percent less time with effusion during the first postoperative year (a mean of 128 days in individual studies). However, mean improvements in hearing were modest and diminished after six to nine months. The benefits diminish because the hearing of children treated with watchful waiting improves as the effusion resolves over time. In otherwise healthy children, there were no proven short-term benefits in language development or cognition. (See
         <a class="local">
          'Tympanostomy tubes'
         </a>
         below.)
        </p>
        <p>
         One of the included trials, in which children (younger than three years) with persistent middle ear effusion were randomly assigned to prompt or delayed insertion of tympanostomy tubes, provides additional support for an initial period of watchful waiting in children who are not at risk for speech, language, or learning problems [
         <a href="#rid40">
          40
         </a>
         ]. Delayed insertion of tympanostomy tubes occurred up to nine months later if the effusion had not cleared spontaneously; by the 9- to 11-year follow-up, 55 percent had not received tubes [
         <a href="#rid41">
          41
         </a>
         ]. Developmental (speech, language, cognition, and psychosocial) outcomes were assessed at 3, 4, 6, and 9 to 11 years of age and were the same between groups [
         <a href="#rid40">
          40-43
         </a>
         ]. (See
         <a class="local">
          'Tympanostomy tubes'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1673680819">
         <span class="h3">
          Follow-up
         </span>
         <span class="headingEndMark">
          —
         </span>
         For the majority of children with OME who are managed with watchful waiting, clinical evaluation (including pneumatic otoscopy and developmental surveillance) and hearing tests (including tympanometry) should be repeated every three to six months [
         <a href="#rid17">
          17
         </a>
         ]. Developmental surveillance and hearing evaluation are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation", section on 'Formal audiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/615.html" rel="external">
          "Developmental-behavioral surveillance and screening in primary care", section on 'Approach to surveillance'
         </a>
         .)
        </p>
        <p>
         Observation should continue until the effusion has resolved or the child develops an indication for surgical referral. (See
         <a class="local">
          'Potential indications'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H170941175">
         <span class="h2">
          Tympanostomy tubes
         </span>
        </p>
        <p class="headingAnchor" id="H965442961">
         <span class="h3">
          Potential indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         The decision regarding the placement of tympanostomy tubes should involve the otolaryngologist, parent(s) or caregiver(s), and the primary care provider.
        </p>
        <p>
         Potential indications for tympanostomy tubes include [
         <a href="#rid1">
          1,2,17
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         OME in children who are at risk for speech, language, or learning problems, regardless of hearing status; referral within three months is recommended (see
         <a class="local">
          'Children at risk for speech, language, or learning issues'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tympanic membrane changes (eg, retraction pockets  (
         <a class="graphic graphic_picture graphicRef103800 graphicRef103801" href="/z/d/graphic/103800.html" rel="external">
          picture 2A-B
         </a>
         )) (see
         <a class="local">
          'Structural damage to the tympanic membrane or middle ear'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistent OME-associated hearing loss with a hearing threshold of ≥41 dB (see
         <a class="local">
          'Hearing threshold ≥41 dB'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bilateral OME for ≥3 months, unilateral OME for ≥6 months, or recurrent episodes of AOM with cumulative duration of OME for ≥6 of the previous 12 months
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H965442855">
         <span class="h3">
          Potential benefits
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myringotomy and placement of a tympanostomy tube is a definitive means of clearing middle ear fluid, improving effusion-associated conductive hearing loss, and maintaining an air-filled middle ear cavity as long as the tympanostomy tubes remain patent [
         <a href="#rid33">
          33,34
         </a>
         ]. Tympanostomy tubes help to reduce the symptoms of OME (including associated conductive hearing loss) during the natural course of resolution [
         <a href="#rid2">
          2,23,44
         </a>
         ]. However, recurrence of OME after extrusion of the tympanostomy tubes occurs in as many as 50 percent of patients, and repeat surgery may be required. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children"
         </a>
         .)
        </p>
        <p>
         Systematic reviews of randomized trials and other comparison studies evaluating the effectiveness of tympanostomy tubes for children with OME have concluded that children with tubes spend less time with effusion during the first postoperative year but the improvements in hearing loss diminish over time [
         <a href="#rid9">
          9,24
         </a>
         ]. In a network meta-analysis of 10 randomized trials, mean hearing thresholds improved (ie, decreased) by 9 dB (95% CI -14 to -3.4 dB) one to three months after insertion of tympanostomy tubes. However, by 12 to 24 months, there was no difference in hearing thresholds between children with tubes and those managed with watchful waiting (mean difference 0, 95% CI -4.0 to 3.4) [
         <a href="#rid9">
          9
         </a>
         ]. Another systematic review concluded that children with tympanostomy tubes spent 32 percent less time with middle ear effusion during the first year of follow-up than children managed with watchful waiting (mean 128 fewer days) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         A systematic review of eight randomized and nonrandomized comparison studies including 1665 children found little evidence that tympanostomy tubes improved cognitive, language, behavioral, or quality-of-life outcomes, but heterogeneity precluded definitive conclusions [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         These systematic review findings of modest and short-lived improvement are inconsistent with the parental and clinical observation that the effects of tympanostomy tubes are beneficial and often dramatic, with a rapid increase in speech following insertion, and observational studies suggesting improved quality of life [
         <a href="#rid28">
          28-30,44-46
         </a>
         ]. As an example, in a prospective survey of parents of 123 children who underwent bilateral placement of tympanostomy tubes, with or without adenoidectomy, postoperative symptom scores decreased by 75 and 60 percent at one and six months, respectively [
         <a href="#rid28">
          28
         </a>
         ]. Parents also reported decreased worry about ear problems at both time points.
        </p>
        <p class="headingAnchor" id="H965442872">
         <span class="h3">
          Risks
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risks of tympanostomy tubes include persistent tympanic membrane perforation, postoperative tympanostomy tube otorrhea (often a result of biofilm formation on the tube), retained tympanostomy tubes requiring another operation for removal, accidental displacement of the tube into the middle ear cavity, focal atrophy of the tympanic membrane, and cholesteatoma. Biofilm colonization of tympanostomy tubes is a common cause of persistent postoperative discharge. They are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children", section on 'Complications and sequelae'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1433862625">
         <span class="h3">
          Follow-up
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postoperative care and follow-up for children who have undergone tympanostomy tube placement are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children", section on 'Postoperative care'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H377255554">
         <span class="h1">
          OTHER INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3862913697">
         <span class="h2">
          Balloon dilation of the Eustachian tube
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic balloon dilation of the Eustachian tube ("tuboplasty") is a minimally invasive procedure for treating chronic, obstructive Eustachian tube dysfunction in adults. Small observational studies indicate that it is also safe and moderately successful in improving OME in children [
         <a href="#rid47">
          47-49
         </a>
         ]. Failure of balloon dilation may be related to thickened mucosa or adenoid tissue obstruction at the Eustachian tube orifice that acts as a barrier to middle ear ventilation and is unresponsive to balloon dilation [
         <a href="#rid50">
          50
         </a>
         ]. Although balloon dilation of the Eustachian tube appears to be promising and experience in children is increasing, additional studies are necessary to determine which children with OME are most likely to benefit.
        </p>
        <p class="headingAnchor" id="H875053440">
         <span class="h2">
          Hearing aids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hearing aids may be warranted for children with OME-associated conductive hearing loss but are discouraged unless tympanostomy tubes cannot be placed [
         <a href="#rid1">
          1
         </a>
         ]. The 2008 National Institute for Health and Care Excellence guidelines (United Kingdom) indicate that hearing aids should be offered to children with persistent bilateral hearing loss as an alternative to surgical intervention when surgery is contraindicated or unacceptable [
         <a href="#rid2">
          2
         </a>
         ]. In observational studies, hearing aids were well accepted by children with OME and their parents and were associated with improvement in hearing, speech, and development (as perceived by parents and teachers) [
         <a href="#rid51">
          51-53
         </a>
         ]. In a retrospective study, only one-half of children with OME who were referred for hearing aids actually received them [
         <a href="#rid53">
          53
         </a>
         ]; for most of the other children, by the time of the appointment, hearing aids were no longer necessary because hearing loss had resolved or was asymptomatic.
        </p>
        <p class="headingAnchor" id="H2342585979">
         <span class="h2">
          Adenoidectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         When the decision is made to manage OME in children ≥4 years of age with surgical intervention, surgical options include adenoidectomy alone, adenoidectomy and tympanostomy tube placement, or tympanostomy tube placement alone [
         <a href="#rid1">
          1
         </a>
         ]. Concomitant adenoidectomy is recommended for children undergoing recurrent tympanostomy tube placement.
        </p>
        <p>
         Decisions about adenoidectomy are made on a case-by-case basis. Adenoidectomy generally is not recommended as the initial approach for children &lt;4 years with persistent OME unless they have a distinct indication for the adenoidectomy independent of OME (eg, nasal obstruction, chronic sinusitis, obstructive sleep apnea) [
         <a href="#rid1">
          1,2
         </a>
         ]. The potential risks (eg, velopharyngeal insufficiency, bleeding, anesthesia necessitating endotracheal intubation) outweigh the uncertain benefits in this age group [
         <a href="#rid1">
          1,37,38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6296.html" rel="external">
          "Tonsillectomy and/or adenoidectomy in children: Indications and contraindications"
         </a>
         .)
        </p>
        <p>
         In systematic reviews of heterogeneous trials, adenoidectomy (with or without tympanostomy tube placement) was beneficial in resolving middle ear fluid compared with unilateral or bilateral tympanostomy tube placement (without adenoidectomy), myringotomy only, and nonsurgical treatment in children ≥4 years [
         <a href="#rid24">
          24,37,38,54,55
         </a>
         ]. However, adenoidectomy had only a small effect (&lt;5 dB) on hearing levels [
         <a href="#rid54">
          54
         </a>
         ]. The effects of adenoidectomy on tympanic membrane changes or cholesteatoma were not studied.
        </p>
        <p class="headingAnchor" id="H3054172055">
         <span class="h1">
          UNPROVEN OR INEFFECTIVE INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H541196729">
         <span class="h2">
          Antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest not using antibiotics for the treatment of persistent OME. Although biofilms appear to play an important role in the pathogenesis of OME, biofilm-associated pathogens generally are unresponsive to antibiotic therapy. (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p>
         A 2016 systematic review of randomized trials found evidence of modest, short-term benefits as well as potential adverse events associated with the use of antibiotics for the treatment of OME [
         <a href="#rid56">
          56
         </a>
         ]. Potential benefits included resolution of OME within two to three months (risk ratio 2, 95% CI 1.6-2.5). Potential harms included increased risk of diarrhea, vomiting, or skin rash (risk ratio 2.2, 95% CI 1.3-3.6). Antibiotics did not reduce the rate of tympanostomy tube insertion or tympanic membrane sequelae. The effects on short-term hearing were inconsistent. Data regarding speech, language, cognitive development, and quality of life were lacking. It is possible that the antibiotic therapy administered in some of the studies included in the systematic review and meta-analysis was insufficient in duration, dose, or spectrum to eradicate bacteria in biofilms. Nonetheless, given the high likelihood of spontaneous resolution, the potential to contribute to antibiotic resistance, and the limited benefits, the risks of antibiotic therapy for persistent OME outweigh the benefits in most situations.
        </p>
        <p>
         Professional society guidelines also recommend against the use of any antibiotics in the treatment of OME [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="local">
          'Society guideline links'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H541196736">
         <span class="h2">
          Oral glucocorticoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest not using oral glucocorticoids for the treatment of OME in children. Although oral glucocorticoids may hasten the short-term resolution of OME, improvement in hearing and functional status is unproven, often transient, and questionable.
        </p>
        <p>
         In a 2023 meta-analysis of seven trials, 10 percent fewer patients who were treated with oral glucocorticoids had persistence of OME at one to six weeks of follow-up compared with those treated with placebo (relative risk [RR] 0.72, 95% CI 0.51-1.02) [
         <a href="#rid57">
          57
         </a>
         ]; however, this decrease may not be clinically meaningful, and data on adverse effects were lacking. In the only multicenter trial that assessed for the resolution of hearing loss, results after five weeks of treatment were similar between groups [
         <a href="#rid58">
          58
         </a>
         ]. In an open-label trial that was not included in the meta-analysis, oral glucocorticoids had no discernable effect on the resolution or duration of middle ear fluid in children with AOM [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Of note, avoidance of oral glucocorticoids is sometimes used as a measure of quality performance in the care of children with OME [
         <a href="#rid60">
          60,61
         </a>
         ].
        </p>
        <p>
         Professional society guidelines and the international OME task force recommend against the use of oral glucocorticoids for the treatment of OME [
         <a href="#rid1">
          1,2,62
         </a>
         ]. (See
         <a class="local">
          'Society guideline links'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H552895820">
         <span class="h2">
          Intranasal glucocorticoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not suggest intranasal glucocorticoids in the treatment of OME unless they are necessary for the treatment of underlying allergic/chronic rhinitis. (See
         <a class="medical medical_review" href="/z/d/html/7526.html" rel="external">
          "Pharmacotherapy of allergic rhinitis", section on 'Approach to specific patient groups'
         </a>
         .)
        </p>
        <p>
         In a 2011 systematic review of heterogeneous randomized trials of systemic and topical nasal glucocorticoids for the treatment of OME in children, intranasal glucocorticoids were not helpful in OME resolution or improving hearing in the short term [
         <a href="#rid63">
          63
         </a>
         ]. Long-term hearing and speech development were not assessed. A subsequent randomized trial confirmed the lack of benefit of intranasal glucocorticoids for children with OME [
         <a href="#rid64">
          64
         </a>
         ]. Avoidance of intranasal glucocorticoids (unless there is adequate documentation of the rationale) is sometimes used as a measure of quality performance in the care of children with OME [
         <a href="#rid60">
          60,61
         </a>
         ]. Professional society guidelines also recommend against the use of nasal glucocorticoids for the treatment of OME [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H541196743">
         <span class="h2">
          Autoinflation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autoinflation refers to the process of allegedly active opening the Eustachian tube by raising intranasal pressure (eg, by forced exhalation with closed mouth and nose, blowing up a balloon through each nostril, or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cmaj.ca%2Fcontent%2Fsuppl%2F2015%2F07%2F27%2Fcmaj.141608.DC2&amp;token=Rti1NBSWdX%2F%2FH%2FlCKGrzlDLoRa4Vo2ztG7r7gJf9OPsHUOCmfaBceMBGgANgmY7yR5ZqhpWWcFwnPWF%2FwzyY1rMvy8ZkGKBoGd7jAgBpekA%3D&amp;TOPIC_ID=87008" target="_blank">
          using a specifically designed nasal balloon
         </a>
         ) [
         <a href="#rid65">
          65,66
         </a>
         ]. It is typically performed at least twice a day for several weeks to three months. The long-term benefit is uncertain.
        </p>
        <p>
         Although we do not recommend autoinflation, it may be an alternative to watchful waiting for the older child who has continued problems with OME and can perform the technique [
         <a href="#rid2">
          2,66
         </a>
         ]. It should not be used in children with active nasal discharge. Autoinflation has minimal adverse effects, but the benefits are uncertain and some children may find it difficult to perform [
         <a href="#rid65">
          65,67,68
         </a>
         ]; in one trial, 12 percent of children (3 to 12 years) were unable to use the balloon [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         In a 2023 systematic review of six trials (670 participants), autoinflation reduced the persistence of OME in the short term in children older than three years of age, although the result was not statistically significant (65 versus 78 percent [RR 0.85, 95% CI 0.69-1.04]) [
         <a href="#rid70">
          70
         </a>
         ]. The five studies that assessed the normalization of hearing favored autoinflation; however, the data were not pooled for meta-analysis. Some children reported increased pain with autoinflation. None of the trials assessed long-term outcomes or language development.
        </p>
        <p class="headingAnchor" id="H377255648">
         <span class="h2">
          Antihistamines and decongestants
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not recommend antihistamines and/or decongestants for the treatment of OME in children. In a 2011 systematic review of 16 randomized trials, treatment with antihistamines and/or decongestants neither reduced the duration of OME nor prevented complications (recurrent OME or acute otitis media) [
         <a href="#rid71">
          71
         </a>
         ]. However, treatment with antihistamines and/or decongestants was associated with an increased risk of side effects (17 versus 6 percent among placebo recipients). Avoidance of antihistamines and decongestants is sometimes used as a measure of quality performance in the care of children with OME [
         <a href="#rid60">
          60,61
         </a>
         ].
        </p>
        <p>
         Professional society guidelines also recommend against the use of antihistamines and decongestants in the management of OME in children [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H377255852">
         <span class="h2">
          Complementary and alternative therapies
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not recommend homeopathic, probiotic, or other complementary and alternative therapies for the treatment of OME in children.
        </p>
        <p>
         The few published studies of homeopathic remedies for middle ear infections or OME have defects in study design, including small sample sizes, lack of randomization or blinding, and lack of validation of the diagnosis [
         <a href="#rid72">
          72,73
         </a>
         ]. In addition, there are no standardized homeopathic regimens for otitis media and no data on appropriate doses or schedules.
        </p>
        <p>
         A systematic review of complementary and alternative medicine interventions for otitis media found some evidence that probiotics may be beneficial in the treatment of OME [
         <a href="#rid74">
          74
         </a>
         ], but additional studies are necessary before probiotics can be recommended [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         The 2008 National Institute for Health and Care Excellence guidelines recommend against homeopathy, cranial osteopathy, acupuncture, dietary modifications (including probiotics), immunostimulants, and massage [
         <a href="#rid2">
          2
         </a>
         ]. The 2022 American Academy of Otolaryngology-Head and Neck Surgery guidelines indicate that no benefits have been shown for chiropractic therapy, special diets, herbal remedies, or other complementary or alternative therapies [
         <a href="#rid1">
          1,17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H965442089">
         <span class="h2">
          Myringotomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myringotomy alone (ie, without tympanostomy tube placement) is ineffective in the management of persistent OME because the incision closes within a few hours [
         <a href="#rid33">
          33,34
         </a>
         ]. Laser-assisted myringotomy may extend the ventilation period to several weeks [
         <a href="#rid76">
          76,77
         </a>
         ]. However, in randomized trials, patients treated with laser myringotomy alone had shorter duration of middle ear ventilation and fewer effusion-free follow-up visits than those who received tympanostomy tubes [
         <a href="#rid78">
          78,79
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1004739010">
         <span class="h1">
          AIRPLANE TRAVEL
         </span>
         <span class="headingEndMark">
          —
         </span>
         Airplane travel for children with otitis media (OME or acute otitis media) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment", section on 'Management of pain'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2277668004">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109085.html" rel="external">
          "Society guideline links: Acute otitis media, otitis media with effusion, and external otitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H170942071">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/83798.html" rel="external">
          "Patient education: Ear tubes (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/1204.html" rel="external">
          "Patient education: Ear infections (otitis media) in children (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H170942251">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions and natural history
         </strong>
         – Otitis media with effusion (OME) is defined as middle ear fluid without acute signs of infection  (
         <a class="graphic graphic_picture graphicRef73735" href="/z/d/graphic/73735.html" rel="external">
          picture 4
         </a>
         ). OME usually resolves spontaneously within six weeks. Approximately 30 to 40 percent of children with OME have recurrent episodes. (See
         <a class="local">
          'Definitions'
         </a>
         above and
         <a class="local">
          'Natural history'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to management
         </strong>
         – The goals of management are to clear the middle ear fluid and restore normal hearing. The primary management options are "watchful waiting" and tympanostomy tube (ventilation tube, grommet) placement. Which option is undertaken and when depends upon coexisting conditions that increase the risk of hearing, speech, language, or learning problems; the severity of OME-associated hearing loss; the duration of the effusion; and whether the effusion is unilateral or bilateral  (
         <a class="graphic graphic_algorithm graphicRef117272" href="/z/d/graphic/117272.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Choice of intervention'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Risk for speech, language, or learning problems
         </strong>
         – "At-risk" children are those who have or are at risk for speech, language, or learning problems. This includes children with hearing loss independent of OME, neurodevelopmental disorders, craniofacial disorders (eg, cleft palate), and uncorrectable visual impairment.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For children with OME who are at risk for speech, language, or learning problems, we suggest early surgical referral (ie, within three months) for tympanostomy tube placement (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). (See
         <a class="local">
          'Children at risk for speech, language, or learning issues'
         </a>
         above and
         <a class="local">
          'Tympanostomy tubes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Structural damage to the tympanic membrane or middle ear
         </strong>
         – Prompt surgical referral is warranted for children who have structural damage to the tympanic membrane or middle ear (eg, retraction pocket  (
         <a class="graphic graphic_picture graphicRef103800 graphicRef103801" href="/z/d/graphic/103800.html" rel="external">
          picture 2A-B
         </a>
         ), cholesteatoma  (
         <a class="graphic graphic_picture graphicRef76079 graphicRef103803" href="/z/d/graphic/76079.html" rel="external">
          picture 3A-B
         </a>
         )). (See
         <a class="local">
          'Structural damage to the tympanic membrane or middle ear'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hearing threshold ≥41 dB
         </strong>
         – For children with persistent OME-associated hearing loss with a hearing threshold of ≥41 dB, we recommend prompt surgical referral for tympanostomy tube placement (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). (See
         <a class="local">
          'Hearing threshold ≥41 dB'
         </a>
         above and
         <a class="local">
          'Tympanostomy tubes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hearing threshold 16 to 40 dB
         </strong>
         – The management of OME-associated conductive hearing loss with a hearing threshold of 16 to 40 dB in children without speech, language, or learning problems is determined on a case-by-case basis, after a discussion of the risks and benefits of watchful waiting versus tympanostomy tube placement. (See
         <a class="local">
          'Hearing threshold 16 to 40 dB'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hearing threshold ≤15 dB
         </strong>
         – For children without speech, language, or developmental problems and with a hearing threshold of ≤15 dB (ie, normal hearing), we recommend watchful waiting (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ). Children who are managed with watchful waiting should be reevaluated (with pneumatic otoscopy, developmental surveillance, and hearing testing) every three to six months until the effusion has resolved or the child develops an indication for surgical referral. (See
         <a class="local">
          'Normal hearing'
         </a>
         above and
         <a class="local">
          'Watchful waiting'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Unproven or ineffective interventions
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest
         <strong>
          not
         </strong>
         using antibiotics in the management of children with OME (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ); the benefits are generally transient. We suggest
         <strong>
          not
         </strong>
         using oral or intranasal glucocorticoids in the management of OME (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ); although they may hasten the resolution of OME, improvement in hearing and functional status is unproven. (See
         <a class="local">
          'Antibiotics'
         </a>
         above and
         <a class="local">
          'Oral glucocorticoids'
         </a>
         above and
         <a class="local">
          'Intranasal glucocorticoids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We recommend
         <strong>
          not
         </strong>
         using antihistamines or decongestants routinely in the management of OME in children, as no benefits have been observed. (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ). (See
         <a class="local">
          'Antihistamines and decongestants'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3579537125">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Jerome Klein, MD, and Stephen Pelton, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg 2016; 154:S1.
          </a>
         </li>
         <li class="breakAll">
          Otitis media with effusion in under 12s, National Institute for Health and Care Excellence (NICE), London 2023.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tos M. Epidemiology and natural history of secretory otitis. Am J Otol 1984; 5:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson IG, Dunleavey J, Bain J, Robinson D. The natural history of otitis media with effusion--a three-year study of the incidence and prevalence of abnormal tympanograms in four South West Hampshire infant and first schools. J Laryngol Otol 1994; 108:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope 2003; 113:1645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teele DW, Klein JO, Rosner BA. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol Suppl 1980; 89:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Principi N, Marchisio P, Esposito S. Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention. Expert Rev Anti Infect Ther 2016; 14:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schilder AG, Chonmaitree T, Cripps AW, et al. Otitis media. Nat Rev Dis Primers 2016; 2:16063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steele DW, Adam GP, Di M, et al. Effectiveness of Tympanostomy Tubes for Otitis Media: A Meta-analysis. Pediatrics 2017; 139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tapiainen T, Kujala T, Renko M, et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatr 2014; 168:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruohola A, Laine MK, Tähtinen PA. Effect of Antimicrobial Treatment on the Resolution of Middle-Ear Effusion After Acute Otitis Media. J Pediatric Infect Dis Soc 2018; 7:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fria TJ, Cantekin EI, Eichler JA. Hearing acuity of children with otitis media with effusion. Arch Otolaryngol 1985; 111:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silman S, Silverman CA, Arick DS. Pure-tone assessment and screening of children with middle-ear effusion. J Am Acad Audiol 1994; 5:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keogh T, Kei J, Driscoll C, Khan A. Children with minimal conductive hearing impairment: speech comprehension in noise. Audiol Neurootol 2010; 15:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordon MA, Grunstein E, Burton WB. The effect of the season on otitis media with effusion resolution rates in the New York Metropolitan area. Int J Pediatr Otorhinolaryngol 2004; 68:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Balen FA, de Melker RA. Persistent otitis media with effusion: can it be predicted? A family practice follow-up study in children aged 6 months to 6 years. J Fam Pract 2000; 49:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld RM, Tunkel DE, Schwartz SR, et al. Clinical Practice Guideline: Tympanostomy Tubes in Children (Update). Otolaryngol Head Neck Surg 2022; 166:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Browning GG, Rovers MM, Williamson I, et al. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2010; :CD001801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuo CL, Tsao YH, Cheng HM, et al. Grommets for otitis media with effusion in children with cleft palate: a systematic review. Pediatrics 2014; 134:983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis JM, Elfenbein J, Schum R, Bentler RA. Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. J Speech Hear Disord 1986; 51:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karchmer MA, Allen TE. The functional assessment of deaf and hard of hearing students. Am Ann Deaf 1999; 144:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carney AE, Moeller MP. Treatment efficacy: hearing loss in children. J Speech Lang Hear Res 1998; 41:S61.
          </a>
         </li>
         <li class="breakAll">
          https://effectivehealthcare.ahrq.gov/ehc/products/387/1485/otitis-media-executive-130504.pdf (Accessed on June 01, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace IF, Berkman ND, Lohr KN, et al. Surgical treatments for otitis media with effusion: a systematic review. Pediatrics 2014; 133:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Venekamp RP, Mick P, Schilder AG, Nunez DA. Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database Syst Rev 2018; 5:CD012017.
          </a>
         </li>
         <li class="breakAll">
          Bluestone CD, Klein JO. Management. In: Otitis Media in Infants and Children, 4th ed, BC Decker, Hamilton, ON 2007. p.213.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gravel JS, Wallace IF. Effects of otitis media with effusion on hearing in the first 3 years of life. J Speech Lang Hear Res 2000; 43:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richards M, Giannoni C. Quality-of-life outcomes after surgical intervention for otitis media. Arch Otolaryngol Head Neck Surg 2002; 128:776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld RM, Bhaya MH, Bower CM, et al. Impact of tympanostomy tubes on child quality of life. Arch Otolaryngol Head Neck Surg 2000; 126:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brouwer CN, Maillé AR, Rovers MM, et al. Health-related quality of life in children with otitis media. Int J Pediatr Otorhinolaryngol 2005; 69:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teele DW, Klein JO, Chase C, et al. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group. J Infect Dis 1990; 162:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts JE, Burchinal MR, Zeisel SA. Otitis media in early childhood in relation to children's school-age language and academic skills. Pediatrics 2002; 110:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandel EM, Rockette HE, Bluestone CD, et al. Myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg 1989; 115:1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandel EM, Rockette HE, Bluestone CD, et al. Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J 1992; 11:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boston M, McCook J, Burke B, Derkay C. Incidence of and risk factors for additional tympanostomy tube insertion in children. Arch Otolaryngol Head Neck Surg 2003; 129:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schilder AG, Marom T, Bhutta MF, et al. Panel 7: Otitis Media: Treatment and Complications. Otolaryngol Head Neck Surg 2017; 156:S88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boonacker CW, Rovers MM, Browning GG, et al. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis. Health Technol Assess 2014; 18:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mikals SJ, Brigger MT. Adenoidectomy as an adjuvant to primary tympanostomy tube placement: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2014; 140:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts JE, Rosenfeld RM, Zeisel SA. Otitis media and speech and language: a meta-analysis of prospective studies. Pediatrics 2004; 113:e238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med 2001; 344:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paradise JL, Feldman HM, Campbell TF, et al. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med 2007; 356:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paradise JL, Dollaghan CA, Campbell TF, et al. Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Pediatrics 2003; 112:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paradise JL, Campbell TF, Dollaghan CA, et al. Developmental outcomes after early or delayed insertion of tympanostomy tubes. N Engl J Med 2005; 353:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hellström S, Groth A, Jörgensen F, et al. Ventilation tube treatment: a systematic review of the literature. Otolaryngol Head Neck Surg 2011; 145:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karkanevatos A, Lesser TH. Grommet insertion in children: a survey of parental perceptions. J Laryngol Otol 1998; 112:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yazici A, Coskun ME. The effect of ventilation tube insertion to the health-related quality of life in a group of children in Southeast Anatolia. Clin Otolaryngol 2018; 43:1578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tisch M, Maier H, Sudhoff H. Balloon dilation of the Eustachian tube: clinical experience in the management of 126 children. Acta Otorhinolaryngol Ital 2017; 37:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leichtle A, Hollfelder D, Wollenberg B, Bruchhage KL. Balloon Eustachian Tuboplasty in children. Eur Arch Otorhinolaryngol 2017; 274:2411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenckel F, Kappo N, Gliese A, et al. Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Estève) in outcomes measurement. Eur Arch Otorhinolaryngol 2015; 272:3677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christov F, Gluth MB. Histopathology of the Mucosa of Eustachian Tube Orifice at the Middle Ear in Chronic Otitis Media With Effusion: Possible Insight Into Tuboplasty Failure. Ann Otol Rhinol Laryngol 2018; 127:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flanagan PM, Knight LC, Thomas A, et al. Hearing aids and glue ear. Clin Otolaryngol Allied Sci 1996; 21:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jardine AH, Griffiths MV, Midgley E. The acceptance of hearing aids for children with otitis media with effusion. J Laryngol Otol 1999; 113:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gan RWC, Overton P, Benton C, Daniel M. Hearing aids for otitis media with effusion: Do children use them? Int J Pediatr Otorhinolaryngol 2017; 99:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Aardweg MT, Schilder AG, Herkert E, et al. Adenoidectomy for otitis media in children. Cochrane Database Syst Rev 2010; :CD007810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacKeith S, Mulvaney CA, Galbraith K, et al. Adenoidectomy for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2023; 10:CD015252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Venekamp RP, Burton MJ, van Dongen TM, et al. Antibiotics for otitis media with effusion in children. Cochrane Database Syst Rev 2016; :CD009163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulvaney CA, Galbraith K, Webster KE, et al. Topical and oral steroids for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2023; 12:CD015255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francis NA, Cannings-John R, Waldron CA, et al. Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial. Lancet 2018; 392:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ranakusuma RW, McCullough AR, Safitri ED, et al. Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study). Pilot Feasibility Stud 2020; 6:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lannon C, Peterson LE, Goudie A. Quality measures for the care of children with otitis media with effusion. Pediatrics 2011; 127:e1490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel MM, Eisenberg L, Witsell D, Schulz KA. Assessment of acute otitis externa and otitis media with effusion performance measures in otolaryngology practices. Otolaryngol Head Neck Surg 2008; 139:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon F, Haggard M, Rosenfeld RM, et al. International consensus (ICON) on management of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck Dis 2018; 135:S33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2011; :CD001935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hussein A, Fathy H, Amin SM, Elsisy N. Oral steroids alone or followed by intranasal steroids versus watchful waiting in the management of otitis media with effusion. J Laryngol Otol 2017; 131:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perera R, Glasziou PP, Heneghan CJ, et al. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database Syst Rev 2013; :CD006285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson I, Vennik J, Harnden A, et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ 2015; 187:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson I. Otitis media with effusion in children. BMJ Clin Evid 2011; 2011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggard M. Commentary:plausible candidates for treatment of glue ear-is one issue really three? BMJ 1999; 318:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanshard JD, Maw AR, Bawden R. Conservative treatment of otitis media with effusion by autoinflation of the middle ear. Clin Otolaryngol Allied Sci 1993; 18:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webster KE, Mulvaney CA, Galbraith K, et al. Autoinflation for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2023; 9:CD015253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2011; :CD003423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrison H, Fixsen A, Vickers A. A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children. Complement Ther Med 1999; 7:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs J, Springer DA, Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis J 2001; 20:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skovbjerg S, Roos K, Holm SE, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 2009; 94:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marom T, Marchisio P, Tamir SO, et al. Complementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic Review. Medicine (Baltimore) 2016; 95:e2695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen D, Shechter Y, Slatkine M, et al. Laser myringotomy in different age groups. Arch Otolaryngol Head Neck Surg 2001; 127:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szeremeta W, Parameswaran MS, Isaacson G. Adenoidectomy with laser or incisional myringotomy for otitis media with effusion. Laryngoscope 2000; 110:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koopman JP, Reuchlin AG, Kummer EE, et al. Laser myringotomy versus ventilation tubes in children with otitis media with effusion: a randomized trial. Laryngoscope 2004; 114:844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Eredità R, Shah UK. Contact diode laser myringotomy for medium-duration middle ear ventilation in children. Int J Pediatr Otorhinolaryngol 2006; 70:1077.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 87008 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26832942" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical Practice Guideline: Otitis Media with Effusion (Update).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26832942" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical Practice Guideline: Otitis Media with Effusion (Update).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6542752" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Epidemiology and natural history of secretory otitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7829943" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The natural history of otitis media with effusion--a three-year study of the incidence and prevalence of abnormal tympanograms in four South West Hampshire infant and first schools.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14520089" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Natural history of untreated otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6778349" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology of otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26853095" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27604644" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28562283" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Effectiveness of Tympanostomy Tubes for Otitis Media: A Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24797294" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28340091" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Effect of Antimicrobial Treatment on the Resolution of Middle-Ear Effusion After Acute Otitis Media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4038450" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Hearing acuity of children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8075413" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Pure-tone assessment and screening of children with middle-ear effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19451707" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Children with minimal conductive hearing impairment: speech comprehension in noise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14725986" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The effect of the season on otitis media with effusion resolution rates in the New York Metropolitan area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10923569" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Persistent otitis media with effusion: can it be predicted? A family practice follow-up study in children aged 6 months to 6 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35138954" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Clinical Practice Guideline: Tympanostomy Tubes in Children (Update).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20927726" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25287451" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Grommets for otitis media with effusion in children with cleft palate: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3945060" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10369003" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The functional assessment of deaf and hard of hearing students.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9493747" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Treatment efficacy: hearing loss in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9493747" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Treatment efficacy: hearing loss in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24394689" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Surgical treatments for otitis media with effusion: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29741289" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Grommets (ventilation tubes) for recurrent acute otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29741289" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Grommets (ventilation tubes) for recurrent acute otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10877434" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Effects of otitis media with effusion on hearing in the first 3 years of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12117333" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Quality-of-life outcomes after surgical intervention for otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10807325" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Impact of tympanostomy tubes on child quality of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16005345" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Health-related quality of life in children with otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2387994" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12359782" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Otitis media in early childhood in relation to children's school-age language and academic skills.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2789777" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Myringotomy with and without tympanostomy tubes for chronic otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1565550" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12622537" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Incidence of and risk factors for additional tympanostomy tube insertion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28372534" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Panel 7: Otitis Media: Treatment and Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24438691" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24287958" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Adenoidectomy as an adjuvant to primary tympanostomy tube placement: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14993583" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Otitis media and speech and language: a meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11309632" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17229952" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Tympanostomy tubes and developmental outcomes at 9 to 11 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12897272" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16093466" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Developmental outcomes after early or delayed insertion of tympanostomy tubes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21632976" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Ventilation tube treatment: a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9850314" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Grommet insertion in children: a survey of parental perceptions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30160377" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The effect of ventilation tube insertion to the health-related quality of life in a group of children in Southeast Anatolia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29327736" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Balloon dilation of the Eustachian tube: clinical experience in the management of 126 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28283791" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Balloon Eustachian Tuboplasty in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25524643" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Estève) in outcomes measurement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30187761" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Histopathology of the Mucosa of Eustachian Tube Orifice at the Middle Ear in Chronic Otitis Media With Effusion: Possible Insight Into Tuboplasty Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8889292" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Hearing aids and glue ear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10474663" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The acceptance of hearing aids for children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28688552" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Hearing aids for otitis media with effusion: Do children use them?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20091650" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Adenoidectomy for otitis media in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37870083" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Adenoidectomy for otitis media with effusion (OME) in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27290722" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Antibiotics for otitis media with effusion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38088821" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Topical and oral steroids for otitis media with effusion (OME) in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30152390" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32874679" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21606146" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Quality measures for the care of children with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18922333" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Assessment of acute otitis externa and otitis media with effusion performance measures in otolaryngology practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29398506" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : International consensus (ICON) on management of otitis media with effusion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21563132" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28807086" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Oral steroids alone or followed by intranasal steroids versus watchful waiting in the management of otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23728660" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Autoinflation for hearing loss associated with otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26216608" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21477396" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Otitis media with effusion in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10383203" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Commentary:plausible candidates for treatment of glue ear-is one issue really three?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8365006" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Conservative treatment of otitis media with effusion by autoinflation of the middle ear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37750500" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Autoinflation for otitis media with effusion (OME) in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21901683" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Antihistamines and/or decongestants for otitis media with effusion (OME) in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10581822" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11224838" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18713796" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26871802" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Complementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11255469" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Laser myringotomy in different age groups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10718416" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Adenoidectomy with laser or incisional myringotomy for otitis media with effusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15126741" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Laser myringotomy versus ventilation tubes in children with otitis media with effusion: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16406076" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Contact diode laser myringotomy for medium-duration middle ear ventilation in children.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
